Patent Assignment
Reel/Frame 035653/0441
Security Interest
Recorded: 2015-05-15
Pages: 6
Assignor
NAVIDEA BIOPHARMACEUTICALS, INC.
Executed: 2015-05-15
Assignees
CAPITAL ROYALTY PARTNERS II L.P.
1000 MAIN STREET, SUITE 2500, HOUSTON, TEXAS, 77002
CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.
1000 MAIN STREET, SUITE 2500, HOUSTON, CALIFORNIA, 77002
PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
1000 MAIN STREET, SUITE 2500, HOUSTON, TEXAS, 77002
Covered Properties
(13)
Compositions, Methods and Kits for Diagnosing and Treating CD206 Expressing Cell-Related Disorders
PCT:
PCT/US2014/047708 ↗
Macromolecular carrier for drug and diagnostic agent delivery
Patent:
6,409,990 →
Application:
09/569,466 →
Novel Heteroaryl Substituted Benzoxazoles
Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709
Novel Heteroaryl Substituted Benzothiazoles
Compounds Suitable as Precursors to Compounds That Are Useful for Imaging Amyloid Deposits
Novel Heteroaryl Substituted Benzothiazoles
Compositions for Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Compounds Suitable as Precursors to Compounds That Are Useful for Imaging Amyloid Deposits
Compositions for Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Compounds Suitable as Precursors to Compounds That Are Useful for Imaging Amyloid Deposits
Compositions, Methods and Kits for Diagnosing and Treating CD206 Expressing Cell-Related Disorders
Application:
14/338,332 →
Publication:
US 2015/0023876
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/106,194 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 12, 2000
From: VERA, DAVID R.
To: CALIFORNIA, UNIVERSITY OF THE REGENTS, THE
Reel/Frame 010805/0371 →
Assignment of Assignor's Interest
Sep 12, 2007
From: MALMSTROM, JONAS; PYRING, DAVID; SLIVO, CAN; SOHN, DANIEL
To: ASTRAZENECA AB
Reel/Frame 019819/0898 →
Assignment of Assignor's Interest
Mar 6, 2008
From: ARZEL, ERWAN; SWAHN, BRITT-MARIE; WENSBO, DAVID
To: ASTRAZENECA AB
Reel/Frame 020620/0192 →
Assignment of Assignor's Interest
Jul 28, 2008
From: GRAVENFORS, YLVA; JONASSON, CATRIN; MALMSTROM, JONAS; PYRING, DAVID
To: ASTRAZENECA AB
Reel/Frame 021303/0422 →
Assignment of Assignor's Interest
Oct 5, 2009
From: BJORK, SETH; JOHNSTROM, PETER; NILSSON, NILS ANDERS; RUDA, KATINKA
To: ASTRAZENECA AB
Reel/Frame 023325/0674 →
Change of Name
Aug 30, 2013
From: NEOPROBE CORPORATION
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 031125/0597 →
Assignment of Assignor's Interest
Sep 27, 2013
From: ASTRAZENECA AB
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 031296/0347 →
Assignment of Assignor's Interest
Jan 7, 2014
From: BJÖRK, SETH; JOHNSTRÖM, PETER; NILSSON, NILS ANDERS; RUDA, KATINKA
To: ASTRAZENECA AB
Reel/Frame 031908/0476 →
Assignment of Assignor's Interest
Jan 7, 2014
From: BJÖRK, SETH; JOHNSTRÖM, PETER; NILSSON, NILS ANDERS; RUDA, KATINKA
To: ASTRAZENECA AB
Reel/Frame 031909/0054 →
Assignment of Assignor's Interest
Sep 2, 2015
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 036477/0455 →
Release of Security Interest
Dec 24, 2015
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 037357/0256 →
Change of Name
Jan 13, 2016
From: NEOPROBE CORPORATION
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 037512/0596 →
Assignment of Assignor's Interest
Jan 13, 2016
From: MAGNESON, GERALD R.; ORAHOOD, RICHARD C.
To: NEOPROBE CORPORATION
Reel/Frame 037481/0778 →
Assignment of Assignor's Interest
May 9, 2016
From: COPE, FREDERICK O.; BLUE, MICHAEL S.; METZ, WENDY L.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 038519/0060 →
Assignment of Assignor's Interest
May 9, 2016
From: SCHLESINGER, LARRY S.
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 038519/0221 →
Release of Security Interest
Mar 9, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 041518/0749 →
Assignment of Assignor's Interest
Mar 20, 2017
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CARDINAL HEALTH 414, LLC
Reel/Frame 041645/0574 →
Assignment of Assignor's Interest
Sep 1, 2020
From: THE OHIO STATE UNIVERSITY
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 053661/0639 →